Jordan Guyon

PharmD - CEO and Co-Founder

Jordan brings his experience in corporate management, drug development operations and financing in the biopharmaceutical industry. Prior to start the GAOMA venture, he held the positions of Deputy General Director and COO at NETRIS Pharma, a clinical-stage biotech, and of Business Modeling Officer at Merck Serono. Jordan graduated from the University of Lyon (PharmD) and from EM Lyon Business School.

Selena Bodennec

PhD – CSO and Co-founder

Skilled in molecular and cell biology, with particular experience in lipid biochemistry. Selena investigated lipid metabolism of marine organisms by establishing connection between the environmental changes and phospholipid metabolism of marine organisms. This work contributed to the discovery of the lipidic vectors. Formerly active in research trial with lipid drugs. Weizmann Institute of Science graduate.

Laurent Bezin

PhD – Senior Scientist and Co-founder

Expert in molecular and cell neurobiology, neuroinflammation, behavior and epilepsy. Deputy Director of the Lyon Neuroscience Research Center and the European Epilepsy Institute. Co-head of the TIGER team. VP of two associations, aimed at improving the quality of life of people with epilepsy or pervasive developmental disorders through meditation and a multi-sensory enrichment program.

Amor Belmeguenai

PhD – Senior Scientist and Co-founder

Over the last decade, Amor has developed a solid experience in the development and evaluation of innovative therapeutic strategies for cognitive impairment in many neurological disorders, including epilepsy. Amor’s efforts are particularly devoted to the combination paradigm of pharmacological and non-pharmacological approaches to better prevent or treat epilepsy and its comorbidities. Amor Belmeguenai is Associate Professor at the University Claude Bernard Lyon 1.

Jacques Bodennec

PhD – Senior Scientist and Co-founder

Jacques research experience lies within biochemistry and physiology of complex lipids. He particularly specialized in the in vivo study of glycerophospholipids and sphingolipids metabolism and functions in normal and pathophysiological conditions. Jacques’s efforts are particularly devoted to the design and synthesis of lipids and derivatives of pharmaceutical interest. Jacques is associated Professor at the University Claude Bernard Lyon 1 and co-founder of a previous biotech company.

Leadership team

Jordan Guyon

PharmD - CEO and Co-Founder

Selena Bodennec

PhD – CSO and Co-founder

Laurent Bezin

PhD – Senior Scientist and Co-founder

Amor Belmeguenai

PhD – Senior Scientist and Co-founder

Jacques Bodennec

PhD – Senior Scientist and Co-founder